# HEALEY ALS Platform Trial - Regimen I NUZ-001

> **NCT07410806** · PHASE2,PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Merit E. Cudkowicz, MD** · enrollment: 160 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **DRUG:** NUZ-001
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT07410806
- **Lead sponsor:** Merit E. Cudkowicz, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-02-16
- **Primary completion:** 2027-07-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07410806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07410806, "HEALEY ALS Platform Trial - Regimen I NUZ-001". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07410806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*